Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorCelik, Oguzhan
dc.contributor.authorCil, Cem
dc.contributor.authorBasaran, Ozcan
dc.contributor.authorDemirci, Erkan
dc.contributor.authorTanik, Veysel Ozan
dc.contributor.authorAltuntas, Emine
dc.contributor.authorBiteker, Murat
dc.date.accessioned2021-11-01T15:06:16Z
dc.date.available2021-11-01T15:06:16Z
dc.date.issued2021
dc.identifier.issn2146-3123
dc.identifier.issn2146-3131
dc.identifier.urihttps://doi.org/10.5152/balkanmedj.2021.21143
dc.identifier.urihttps://hdl.handle.net/11491/7531
dc.description.abstractBackground: Indications and appropriateness of aspirin use have not been well investigated in Turkey. Aims: To investigate the prescription patterns and appropriateness of aspirin in a real-world clinical setting. Study Design: Cross-sectional study. Methods: The Appropriateness of Aspirin Use in Medical Outpatients: A Multicenter, Observational Study (ASSOS) is a cross-sectional and multicenter study that included 5007 consecutive patients aged 18 or over who presented to 30 different cardiology outpatient clinics from 14 cities throughout Turkey. Only patients using aspirin (80-325 mg) were included. The study population was divided into 2 groups regarding the use of aspirin: primary prevention (PP) group and secondary prevention (SP) group. The indication of aspirin use was evaluated following the 2016 European Society of Cardiology (ESC) and the 2016 United States Preventative Services Task Force (USPTF) guidelines in the PP group. Results: A total of 5007 patients (mean age 62.15 +/- 11.05, 39% female) were enrolled. The PP group included 1132 (22.6%) patients, and the SP group included 3875 (77.4%) patients. Of the 1132 patients, inappropriate use of aspirin was determined in 100% of the patients according to the ESC guidelines, and 71% of the patients according to the USPTF guidelines. Multivariate logistic regression analysis showed age OR: 0.98 CI (0.97-0.99) P=.037, smoking OR: 0.60 CI (0.44- 0.82) P=.001, heart failure OR: 2.11 CI (1.14-3.92) P=.017, hypertension OR: 0.51 CI (0.36-0.74) P<.001, diabetes mellitus OR: 0.34 CI (0.25-0.47) P<.001, oral anticoagulant use OR: 3.01 CI (1.10-8.25) P=.032, and female sex OR: 2.73 CI (1.96-3.80) P<.001 were independent predictors of inappropriate aspirin use in PP patients. Conclusion: Although there are considerable differences between the USPTF and the ESC guidelines with respect to recommendations for aspirin use in PP, inappropriate use of aspirin in Turkey is frequent in real-world practice for both guidelines. Besides, heart failure, oral anticoagulant use, and the female sex of the patients were independent predictors of inappropriate use of aspirin.en_US
dc.language.isoengen_US
dc.publisherAvesen_US
dc.relation.ispartofBalkan Medical Journalen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keywords]en_US
dc.titleInappropriate Use of Aspirin in Real-Life Cardiology Practice: Results from the Appropriateness of Aspirin Use in Medical Outpatients: A Multicenter, Observational Study (ASSOS) Studyen_US
dc.typearticleen_US
dc.department[Belirlenecek]en_US
dc.identifier.volume38en_US
dc.identifier.issue3en_US
dc.identifier.startpage183en_US
dc.identifier.endpage189en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-temp[Celik, Oguzhan; Cil, Cem; Basaran, Ozcan; Ozlek, Bulent; Ozlek, Eda; Gokcek, Aysel; Dogan, Volkan; Biteker, Murat] Mugla Sitki Kocman Univ, Dept Cardiol, Sch Med, Mugla, Turkey; [Demirci, Erkan] Kayseri City Hosp, Clin Cardiol, Kayseri, Turkey; [Tanik, Veysel Ozan] Ankara Diskapi Yildirim Beyazit Training & Res Ho, Dept Cardiol, Ankara, Turkey; [Altuntas, Emine] Sancaktepe Sehit Prof Dr Ilhan Varank Training &, Dept Cardiol, Istanbul, Turkey; [Sancar, Kadriye Memic] Mehmet Akif Ersoy Training & Res Hosp, Dept Cardiol, Istanbul, Turkey; [Orscelik, Ozcan] Mersin Univ, Dept Cardiol, Sch Med, Mersin, Turkey; [Yetim, Mucahit; Bekar, Lutfu; Karaarslan, Osman] Hitit Univ, Dept Cardiol, Corum Erol Olcok Training & Res Hosp, Corm, Turkey; [Dogan, Tolga] Univ Hlth Sci, Bursa Yuksek Ihtisas Training & Res Hosp, Dept Cardiol, Bursa, Turkey; [Resulzade, Mubariz Murat] Private Hosp Pk Darica Hosp, Clin Cardiol, Kocaeli, Turkey; [Kaya, Caglar] Trakya Univ, Dept Cardiol, Sch Med, Edirne, Turkey; [Kucuk, Emrah] Kiziltepe State Hosp, Clin Cardiol, Mardin, Turkey; [Kiris, Tuncay] Izmir Katip Celebi Univ, Ataturk Training & Res Hosp, Dept Cardiol, Izmir, Turkey; [Demirtas, Abdullah Orhan] Adana City Hosp, Clin Cardiol, Adana, Turkey; [Civan, Murat] Bahcelievler Vital Private Hosp, Dept Cardiol, Istanbul, Turkey; [Asoglu, Ramazan] Adiyaman Univ, Dept Cardiol, Sch Med, Adiyaman, Turkeyen_US
dc.contributor.institutionauthor[Belirlenecek]
dc.identifier.doi10.5152/balkanmedj.2021.21143
dc.authorwosidBekar, Lutfu / A-6945-2019
dc.description.wospublicationidWOS:000657512500007en_US
dc.description.scopuspublicationid2-s2.0-85108188968en_US
dc.description.pubmedpublicationidPubMed: 34142960en_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster